Skip to main content
logo
Avadel Pharmaceuticals plc (AVDL)
21.64
+0.01 (0.05%)
Inactive · Last trade price on Feb 11, 2026

Avadel Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
279.14279.14169.1227.96--
Revenue Growth
65.06%65.06%504.79%---
Gross Profit
263.32263.32153.8427.12--
Operating Income
12.8712.87-42.4-137.85-95.22-85.6
Net Income
64.6764.67-48.83-160.28-137.46-77.33
Earnings Per Share
0.640.64-0.51-2.00-2.29-1.32
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
165.36165.3673.78105.1196.5157.22
Total Debt
36.4636.4636.9536.11131.02145
Net Cash (Debt)
128.9128.936.8269-34.5212.22
Net Cash Growth
250.04%250.04%-46.63%---86.77%
Net Cash Per Share
1.281.280.390.86-0.570.21

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
97.9997.99-46.91-128.51-70.3-77.31
Capital Expenditures
-0.56-0.56---0.72-0.03
Free Cash Flow
97.4397.43-46.91-128.51-71.02-77.34
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
94.33%94.33%90.97%96.97%--
Operating Margin
4.61%4.61%-25.07%-492.97%--
Pretax Margin
22.49%22.49%-29.02%-574.96%--
Profit Margin
23.17%23.17%-28.88%-573.17%--
FCF Margin
34.90%34.90%-27.74%-459.57%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-32.71----
Forward PE
33.1732.06200.19---
P/FCF Ratio
61.8321.71----
PS Ratio
8.427.585.99---